Also trades as: LSBCF (OTC) · $vol 0M
LSB NASDAQ
LakeShore Biopharma Co., Ltd
1W: +1.3%
1M: -2.7%
3M: -25.0%
1Y: -79.4%
3Y: -99.2%
$0.63
Last traded 2025-10-16 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$121M
+59.0% ▲
Capital Expenditures
$18M
+59.6% ▲
4Y CAGR: -35.8%
Free Cash Flow
-$139M
+59.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$139M
-12.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$208M | -$106M | -$145M | -$433M | -$100M |
| Depreciation & Amort. | $28M | $31M | $37M | $42M | $37M |
| Stock-Based Comp. | $77M | $8M | $4M | $10M | $14M |
| Change in Working Capital | -$148M | -$139M | -$93M | -$46M | -$115M |
| Other Non-Cash Items | $5M | $27M | $14M | $154M | $48M |
| Operating Cash Flow | -$247M | -$174M | -$182M | -$295M | -$121M |
| — Investing Activities — | |||||
| Capital Expenditures | -$105M | -$299M | -$57M | -$44M | -$13M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $645K | $8K | $68K | $0 | -$4M |
| Investing Cash Flow | -$104M | -$299M | -$57M | -$44M | -$17M |
| — Financing Activities — | |||||
| Net Debt Issuance | $8M | $365M | $101M | -$79M | -$4M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $217M | $0 | $0 |
| Financing Cash Flow | $739M | $365M | $317M | $205M | -$4M |
| Net Change in Cash | $388M | -$119M | $99M | -$124M | -$139M |
| Cash End of Period | $390M | $885K | $370M | $247M | $107M |
| Free Cash Flow | -$351M | -$300M | -$240M | -$339M | -$139M |